Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 8.18
-0.34 (-3.99%)
At close: Sep 11, 2026
SHE:301301 Revenue
Yili Chuanning Biotechnology had revenue of 1.00B CNY in the quarter ending June 30, 2026, a decrease of -4.60%. This brings the company's revenue in the last twelve months to 4.37B, down -11.12% year-over-year. In the year 2025, Yili Chuanning Biotechnology had annual revenue of 4.62B, down -19.83%.
Revenue (ttm)
4.37B
Revenue Growth
-11.12%
P/S Ratio
4.36
Revenue / Employee
1.40M
Employees
3,126
Market Cap
19.02B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.62B | -1.14B | -19.83% |
| Dec 31, 2024 | 5.76B | 934.97M | 19.38% |
| Dec 31, 2023 | 4.82B | 1.00B | 26.24% |
| Jan 1, 2023 | 3.82B | 588.64M | 18.21% |
| Jan 1, 2022 | 3.23B | -417.40M | -11.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Beijing Tiantan Biological Products | 5.65B |
| Hualan Biological Engineering | 4.36B |
| Xiamen Amoytop Biotech | 4.02B |
| Anhui Anke Biotechnology (Group) | 2.45B |
| Jinyu Bio-technology | 1.53B |
| BrightGene Bio-Medical Technology | 1.36B |
| Sinocelltech Group | 1.25B |
| Acrobiosystems | 950.35M |